Results 221 to 230 of about 22,935 (284)

Two cases (a decade apart) of severe sulfonylurea-positive hypoglycemia associated with inhaled heroin use. [PDF]

JCEM Case Rep
Weisbrot B, Kim KY, Zacharia C, Hwang JL.   +3 more
europepmc   +1 more source

DPP-4 Inhibitors in Female Cancers: Opportunities for Drug Repurposing. [PDF]

Curr Issues Mol Biol
Muddather HF, Schelz Z, Zupkó I.
europepmc   +1 more source

Comparative cardiovascular risk of sulfonylureas with low- and high-affinities for cardiac mitochondrial adenosine triphosphate-sensitive potassium channels versus dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes: A cohort study. [PDF]

Diabetes Obes Metab
Chen MH, Lin LY, Hung TY, Lin TC, Li CY, Lin TH, Chen YH, Liou JT, Wang MT.   +8 more
europepmc   +1 more source

Determinants and predictive performance of reduced muscle mass in elderly patients with type 2 diabetes: a retrospective study. [PDF]

Front Endocrinol (Lausanne)
Wang K, Fu W, Pan H, Dong J.
europepmc   +1 more source

Population attributable fraction of associated factors to adherence to blood glucose self-monitoring in diabetic type 2 patients treated with insulin or sulfonylureas/meglitinides: The results of DiaCare study in Iran. [PDF]

J Educ Health Promot
Mohammadi A, Shafiee G, Olyaeemanesh A, Daroudi R, Aghakhani A, Nasli-Esfahani E, Razi F, Heshmat R, Takian A.   +8 more
europepmc   +1 more source

Engineering Herbicide Cross‐Resistance in Rapeseed by Generating Stacked BnaALS Mutations via Sequential CBE and ABE8e‐SpRY Editing

Plant Biotechnology Journal, Volume 24, Issue 9, Page 5007-5009, September 2026.
Sichao Ren, Wenjing Lei, Jiaqi He, Meng Jia, Yu Liu, Jialin Fan, Yumei Wang, Li Lin, Hui Zhang, Youping Wang, Jian Wu   +10 more
wiley   +1 more source

Rates of hypoglycemia in users of sulfonylureas

Journal of Clinical Epidemiology, 1997
OBJECTIVE: To identify the demographic and clinical characteristics of sulfonylurea users. To assess the risk of hypoglycemia in patients treated with sulfonylureas in clinical practice, and to characterize the risk in relation to the different drugs ...
Tjeerd van Staa, Lucien Abenhaim, Johanne Monette   +2 more
exaly   +11 more sources

Recent Advances in the Synthesis of Sulfonylureas

European Journal of Organic Chemistry, 2021
Sulfonylureas are employed in a variety of applications including use as drugs to treat type II diabetes and as plant growth regulators or herbicides.
Vinicio Zanirato
exaly   +2 more sources

Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin [PDF]

Diabetologia, 2006
Aims/hypothesis: The aim of this study was to evaluate the risk of adverse cardiovascular outcomes in patients with type 2 diabetes newly treated with sulfonylureas and metformin. Subjects and methods: The Diabetes Audit and Research in Tayside Scotland (
Ogston S A, Morris A D, A D Morris
exaly   +2 more sources